Franziska Zabel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Franziska Zabel has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Antonia Fettelschoss-Gabriel
Department of Dermatology University Hospital Zurich Schlieren Switzerland
2 shared publications Martin F. Bachmann
Department of Dermatology University Hospital Zurich Zurich Switzerland
2 shared publicationsThomas M. Kündig
Department of Dermatology, Zurich University Hospital, Zurich, Switzerland
2 shared publicationsAlexander Link
Cytos Biotechnology AG, CH-8952 Zurich-Schlieren, Switzerland; and
1 shared publicationDeepa Mohanan
Department of Dermatology, Zurich University Hospital, 8091 Zurich, Switzerland
1 shared publicationJuliana Bessa
Cytos Biotechnology AG, CH-8952 Zurich-Schlieren, Switzerland; and
1 shared publication
Latest Publications
- 5 January 2017
- Published by Wiley in Immunology
- Vol. 150 (3) , 329-342
Distinct T helper cell dependence of memory B‐cell proliferation versus plasma cell differentiation
Several memory B-cell subclasses with distinct functions have been described, of which the most effective is the class-switched (CS) memory B-cell population. We have previously shown, using virus-like particles (VLPs), that the proliferative potential of these CS memory B cells is limited and they fail to re-enter germinal centres (GCs). However, VLP-specific memory B cells quickly differentiated into secondary plasma cells (PCs) with the virtue of elevated antibody production compared with primary PCs. Whereas the induction of VLP+ memory B cells was strongly dependent on T helper cells, we were wondering whether re-stimulation of VLP+ memory B cells and their differentiation into secondary PCs would also require T helper cells. Global absence of T helper cells led to strongly impaired memory B cell proliferation and PC differentiation. In contrast, lack of interleukin-21 receptor-dependent follicular T helper cells or CD40 ligand signalling strongly affected proliferation of memory B cells, but differentiation into mature secondary PCs exhibiting increased antibody production was essentially normal. This contrasts with primary B-cell responses, where a strong dependence on CD40 ligand but limited importance of interleukin-21 receptor was seen. Hence, T helper cell dependence differs between primary and secondary B-cell responses as well as between memory B-cell proliferation and PC differentiation.
- 5 January 2017
- Published by Wiley in Immunology
- Vol. 150 (3) , 329-342
Distinct T helper cell dependence of memory B‐cell proliferation versus plasma cell differentiation
Several memory B-cell subclasses with distinct functions have been described, of which the most effective is the class-switched (CS) memory B-cell population. We have previously shown, using virus-like particles (VLPs), that the proliferative potential of these CS memory B cells is limited and they fail to re-enter germinal centres (GCs). However, VLP-specific memory B cells quickly differentiated into secondary plasma cells (PCs) with the virtue of elevated antibody production compared with primary PCs. Whereas the induction of VLP+ memory B cells was strongly dependent on T helper cells, we were wondering whether re-stimulation of VLP+ memory B cells and their differentiation into secondary PCs would also require T helper cells. Global absence of T helper cells led to strongly impaired memory B cell proliferation and PC differentiation. In contrast, lack of interleukin-21 receptor-dependent follicular T helper cells or CD40 ligand signalling strongly affected proliferation of memory B cells, but differentiation into mature secondary PCs exhibiting increased antibody production was essentially normal. This contrasts with primary B-cell responses, where a strong dependence on CD40 ligand but limited importance of interleukin-21 receptor was seen. Hence, T helper cell dependence differs between primary and secondary B-cell responses as well as between memory B-cell proliferation and PC differentiation.
- Open Access
- 26 December 2014
- Published by Wiley in European Journal of Immunology
- Vol. 45 (4) , 1238-1247
Protective effect of a germline, IL‐17‐neutralizing antibody in murine models of autoimmune inflammatory disease
Monoclonal antibodies (mAbs) inhibiting cytokines have recently emerged as new drug modalities for the treatment of chronic inflammatory diseases. Interleukin‐17 (IL‐17) is a T‐cell‐derived central mediator of autoimmunity. Immunization with Qβ‐IL‐17, a virus‐like particle based vaccine, has been shown to produce autoantibodies in mice and was effective in ameliorating disease symptoms in animal models of autoimmunity. To characterize autoantibodies induced by vaccination at the molecular level, we generated mouse mAbs specific for IL‐17 and compared them to germline Ig sequences. The variable regions of a selected hypermutated high‐affinity anti‐IL‐17 antibody differed in only three amino acid residues compared to the likely germline progenitor. An antibody, which was backmutated to germline, maintained a surprisingly high affinity (0.5 nM). The ability of the parental hypermutated antibody and the derived germline antibody to block inflammation was subsequently tested in murine models of multiple sclerosis (experimental autoimmune encephalomyelitis), arthritis (collagen‐induced arthritis), and psoriasis (imiquimod‐induced skin inflammation). Both antibodies were able to delay disease onset and significantly reduced disease severity. Thus, the mouse genome unexpectedly encodes for antibodies with the ability to functionally neutralize IL‐17 in vivo.
- 26 December 2014
- Published by Wiley in European Journal of Immunology
- Vol. 45 (4) , 1238-1247
Open AccessProtective effect of a germline, IL‐17‐neutralizing antibody in murine models of autoimmune inflammatory disease
Monoclonal antibodies (mAbs) inhibiting cytokines have recently emerged as new drug modalities for the treatment of chronic inflammatory diseases. Interleukin‐17 (IL‐17) is a T‐cell‐derived central mediator of autoimmunity. Immunization with Qβ‐IL‐17, a virus‐like particle based vaccine, has been shown to produce autoantibodies in mice and was effective in ameliorating disease symptoms in animal models of autoimmunity. To characterize autoantibodies induced by vaccination at the molecular level, we generated mouse mAbs specific for IL‐17 and compared them to germline Ig sequences. The variable regions of a selected hypermutated high‐affinity anti‐IL‐17 antibody differed in only three amino acid residues compared to the likely germline progenitor. An antibody, which was backmutated to germline, maintained a surprisingly high affinity (0.5 nM). The ability of the parental hypermutated antibody and the derived germline antibody to block inflammation was subsequently tested in murine models of multiple sclerosis (experimental autoimmune encephalomyelitis), arthritis (collagen‐induced arthritis), and psoriasis (imiquimod‐induced skin inflammation). Both antibodies were able to delay disease onset and significantly reduced disease severity. Thus, the mouse genome unexpectedly encodes for antibodies with the ability to functionally neutralize IL‐17 in vivo.
- 15 June 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 192 (12) , 5499-5508
Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
Extensive studies have been undertaken to describe naive B cells differentiating into memory B cells at a cellular and molecular level. However, relatively little is known about the fate of memory B cells upon Ag re-encounter. We have previously established a system based on virus-like particles (VLPs), which allows tracking of VLP-specific B cells by flow cytometry as well as histology. Using allotype markers, it is possible to adoptively transfer memory B cells into a naive mouse and track responses of naive and memory B cells in the same mouse under physiological conditions. We have observed that VLP-specific memory B cells quickly differentiated into plasma cells that drove the early onset of a strong humoral IgG response. However, neither IgM+ nor IgG+ memory B cells proliferated extensively or entered germinal centers. Remarkably, plasma cells derived from memory B cells preferentially homed to the bone marrow earlier and secreted increased levels of Abs when compared with primary plasma cells derived from naive B cells. Hence, memory B cells have the unique phenotype to differentiate into highly effective secondary plasma cells.
- 15 June 2014
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 192 (12) , 5499-5508
Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies
Extensive studies have been undertaken to describe naive B cells differentiating into memory B cells at a cellular and molecular level. However, relatively little is known about the fate of memory B cells upon Ag re-encounter. We have previously established a system based on virus-like particles (VLPs), which allows tracking of VLP-specific B cells by flow cytometry as well as histology. Using allotype markers, it is possible to adoptively transfer memory B cells into a naive mouse and track responses of naive and memory B cells in the same mouse under physiological conditions. We have observed that VLP-specific memory B cells quickly differentiated into plasma cells that drove the early onset of a strong humoral IgG response. However, neither IgM+ nor IgG+ memory B cells proliferated extensively or entered germinal centers. Remarkably, plasma cells derived from memory B cells preferentially homed to the bone marrow earlier and secreted increased levels of Abs when compared with primary plasma cells derived from naive B cells. Hence, memory B cells have the unique phenotype to differentiate into highly effective secondary plasma cells.